Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of CXCL2 to preparation of tool for diagnosis or treatment of lung adenocarcinoma

A lung adenocarcinoma and tool technology, applied in the field of tumor diagnosis, treatment, and prognosis prediction, can solve problems such as the inability to meet the early diagnosis of lung cancer

Active Publication Date: 2017-08-11
FOURTH HOSPITAL OF HEBEI MEDICAL UNIV
View PDF8 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, none of the above diagnostic methods can meet the requirements for early diagnosis of lung cancer.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of CXCL2 to preparation of tool for diagnosis or treatment of lung adenocarcinoma
  • Application of CXCL2 to preparation of tool for diagnosis or treatment of lung adenocarcinoma
  • Application of CXCL2 to preparation of tool for diagnosis or treatment of lung adenocarcinoma

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0073] Example 1 Screening of differentially expressed genes

[0074] 1. Materials:

[0075] The surgically resected cancer tissues and paracancerous tissues of 8 patients with primary lung adenocarcinoma were used as experimental samples. All cancer tissues were pathologically confirmed as lung adenocarcinoma. All patients with primary lung adenocarcinoma had not received radiotherapy and chemotherapy before operation, and the clinical data of all cases were complete.

[0076] 2. Obtaining tissue RNA

[0077] Total RNA was extracted from tissue samples, and the concentration and purity of the extracted RNA were detected by Nanodrop2000, the integrity of RNA was detected by agarose gel electrophoresis, and the RIN value was determined by Agilent2100. The total amount of RNA required for a single library construction is 5ug, the concentration is ≥200ng / μL, and the OD260 / 280 is between 1.8 and 2.2.

[0078] 3. Remove rRNA

[0079] A part (>24%) of the long non-coding RNAs i...

Embodiment 2

[0103] Example 2 Large sample validation of differentially expressed genes screened out

[0104] Based on the results of the previous high-throughput transcriptome deep sequencing, we selected the CXCL2 gene for verification according to the size of the P value.

[0105] 1. Sample collection

[0106] According to the method of Example 1, 45 cases of lung adenocarcinoma tissues and corresponding paracancerous tissues were collected.

[0107] 2. Validation at the mRNA level

[0108] 2.1 Extract tissue RNA

[0109] Step is with embodiment 1.

[0110] 2.2 Reverse transcription

[0111] Reverse transcription using Primescript 1 st strand cDNAsynthesis kit kit, the operation steps are as follows:

[0112] (1) Add the following reaction liquid in the microcentrifuge tube, as shown in Table 1:

[0113] Table 1 Reaction liquid

[0114] Reagent dose RNA 2.0μg dNTP 1.0μl Oligo(dT) 2.0μl RNase free dH 2 o

Add to 10.0μl

[0115] (2)...

Embodiment 3

[0139] Example 3 CXCL2 Gene Overexpression

[0140] 1. Plasmid construction

[0141] Amplification primers are designed according to the coding sequence of CXCL2 gene, and the design of primers is well known to those skilled in the art. Amplify the coding sequence of the full-length CXCL2 gene from the cDNA library of adult fetal brain (clontech company, article number: 638831), insert the above cDNA sequence into the eukaryotic cell expression vector pcDNA3.1, and connect the obtained recombinant vector pcDNA3.1 -CXCL2 was used in subsequent experiments.

[0142] 2. Culture and transfection of lung adenocarcinoma cells

[0143] 2.1 Cell culture

[0144] The lung adenocarcinoma cell line A549 was cultured in RPMI1640 medium and 10% fetal bovine serum.

[0145] 2.2 Cell transfection

[0146] (1) The day before transfection, 0.5-2*10 5 Tumor cells were suspended in 500 μl of antibiotic-free medium and seeded into 24-well culture plates.

[0147] (2) On the day of transfec...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a gene marker, and the gene marker is CXCL2. CXCL2 can be used for judging whether a testee is likely to develop lung adenocarcinoma or whether the testee has lung adenocarcinoma. CXCL2 can also be used for preparing a drug for treating lung adenocarcinoma. A novel diagnosis method is provided for clinical diagnosis of lung adenocarcinoma at the molecular level, and a novel drug target is provided for gene therapy of lung adenocarcinoma.

Description

technical field [0001] The present invention relates to the fields of tumor diagnosis, treatment and prognosis prediction, more specifically, the present invention relates to a method for tumor diagnosis and prognosis prediction by means of detecting CXCL2 abnormality; and a tumor therapeutic agent for activating CXCL2 gene or protein. Background technique [0002] Malignant tumors are diseases that seriously endanger human life and health. There are about 1.6 million cancer patients in my country every year. Malignant tumors are surpassing cardiovascular disease as the number one cause of death. Cancer prevention and research is becoming a topic of increasing concern to scientists all over the world. Lung adenocarcinoma (lung adenocarcinoma) is a type of lung cancer and belongs to non-small cell carcinoma. Adenocarcinoma accounts for about 40% of primary lung tumors. Unlike squamous cell lung cancer, lung adenocarcinoma is more likely to occur in women and non-smokers. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68G01N33/68G01N33/574A61K45/00A61P35/00
CPCA61K45/00C12Q1/6886C12Q2600/118C12Q2600/158G01N33/57423G01N33/57484G01N33/68
Inventor 田子强温士旺徐延昭
Owner FOURTH HOSPITAL OF HEBEI MEDICAL UNIV